TSE:HSMHelius Medical Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Helius Medical Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.66 +0.02 (+3.13 %) (As of 07/9/2020 04:00 PM ET) Add Compare Share Today's RangeC$0.64Now: C$0.66▼C$0.6650-Day RangeC$0.53MA: C$0.68▼C$0.9552-Week RangeC$0.35Now: C$0.66▼C$3.11Volume1,500 shsAverage Volume29,090 shsMarket CapitalizationC$25.11 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsHeadlinesSocial Media Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. Helius Medical Technologies, Inc. is headquartered in Newtown, Pennsylvania.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Helius Medical Technologies. Previous Next 2.7 Community Rank Outperform VotesHelius Medical Technologies has received 21 “outperform” votes. (Add your “outperform” vote.)Underperform VotesHelius Medical Technologies has received 18 “underperform” votes. (Add your “underperform” vote.)Community SentimentHelius Medical Technologies has received 53.85% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Helius Medical Technologies and other stocks. Vote “Outperform” if you believe HSM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HSM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldHelius Medical Technologies does not currently pay a dividend.Dividend GrowthHelius Medical Technologies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Helius Medical Technologies insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Helius Medical Technologies are expected to decrease by -100.00% in the coming year, from C$0.12 to C$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Helius Medical Technologies is -1.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Helius Medical Technologies is -1.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHelius Medical Technologies has a P/B Ratio of 4.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.54 out of 5 stars Industry, Sector and Symbol Stock Exchange TSE Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolTSE:HSM Previous Symbol CUSIPN/A CIKN/A Webheliusmedical.com Phone215-944-6100Debt Debt-to-Equity Ratio11.46 Current Ratio2.25 Quick Ratio1.76Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio5.50 P/E GrowthN/A Sales & Book Value Annual SalesC$1.03 million Price / Sales24.47 Cash FlowC$0.13 per share Price / Cash Flow5.13 Book ValueC$0.14 per share Price / Book4.82Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees25 Outstanding Shares38,042,000Market CapC$25.11 million Next Earnings Date8/13/2020 (Estimated) OptionableNot Optionable TSX:HSM Rates by TradingView Receive HSM News and Ratings via Email Sign-up to receive the latest news and ratings for HSM and its competitors with MarketBeat's FREE daily newsletter. Helius Medical Technologies (TSE:HSM) Frequently Asked Questions How has Helius Medical Technologies' stock been impacted by COVID-19 (Coronavirus)? Helius Medical Technologies' stock was trading at C$0.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HSM stock has decreased by 5.7% and is now trading at C$0.66. View which stocks have been most impacted by Coronavirus. When is Helius Medical Technologies' next earnings date? Helius Medical Technologies is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Helius Medical Technologies. How were Helius Medical Technologies' earnings last quarter? Helius Medical Technologies Inc (TSE:HSM) announced its quarterly earnings data on Thursday, May, 7th. The company reported ($0.21) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.23) by $0.02. The company had revenue of $0.28 million for the quarter, compared to the consensus estimate of $0.42 million. View Helius Medical Technologies' earnings history. Has Helius Medical Technologies been receiving favorable news coverage? News coverage about HSM stock has been trending somewhat negative this week, InfoTrie reports. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Helius Medical Technologies earned a news impact score of -1.6 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. View the latest news about Helius Medical Technologies. Who are some of Helius Medical Technologies' key competitors? Some companies that are related to Helius Medical Technologies include Titan Medical (TMD), Somnomed (SOM), Advanced Oncotherapy (AVO), Resonance Health (RHT), REVA Medical (RVA), Kromek Group (KMK), Total Brain (TTB), EMvision Medical Devices (EMV), MRI Interventions (CLPT), MRI Interventions (MRIC), Protech Home Medical (PHM), Polarean Imaging (POLX), Respiri (RSH), Anteo Diagnostics (ADO) and Universal Biosensors (UBI). View all competitors. What other stocks do shareholders of Helius Medical Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Helius Medical Technologies investors own include VanEck Vectors Junior Gold Miners ETF (GDXJ), Sleep Country Canada (ZZZ), Acadian Timber (ADN), Alaris Royalty (AD), Agellan Commercial Real Estate Invtmt TR (ACR.UN), AutoCanada (ACQ), ATCO LTD -CLASS I Common Stock (US funds) (ACO.X), Accord Financial (ACD), Aurora Cannabis (ACB) and Air Canada (AC). Who are Helius Medical Technologies' key executives? Helius Medical Technologies' management team includes the following people: Mr. Philippe Deschamps, Chairman, CEO & Pres (Age 57)Ms. Joyce N. LaViscount, CFO & COO (Age 57)Ms. Jennifer Laux M.B.A., Chief Commercialization Officer (Age 52)Dr. Jonathan Mark Sackier, Chief Medical Officer (Age 61)Diane Carman, Sec. What is Helius Medical Technologies' stock symbol? Helius Medical Technologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HSM." How do I buy shares of Helius Medical Technologies? Shares of HSM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Helius Medical Technologies' stock price today? One share of HSM stock can currently be purchased for approximately C$0.66. How big of a company is Helius Medical Technologies? Helius Medical Technologies has a market capitalization of C$25.11 million and generates C$1.03 million in revenue each year. Helius Medical Technologies employs 25 workers across the globe. What is Helius Medical Technologies' official website? The official website for Helius Medical Technologies is heliusmedical.com. How can I contact Helius Medical Technologies? The company can be reached via phone at 215-944-6100. This page was last updated on 7/9/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
